Skip to main content

Moors & Cabot, Inc.

Position in CRSP — CRISPR Therapeutics AG

CIK 1607239 BOSTON, MA

Position in CRSP

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$367,163
+$131,359 QoQ
Shares Held
6,732
+35.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#249
of 519 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Dec 31, 2023
CallValue
$5,160
CallShares
1,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $4,203,874 across 8 Biotechnology names. CRSP ranks #5 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CRSP
CRISPR Therapeutics AG
This page
6,732 $367,163

All Filings in CRSP

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $367,163 6,732
2026-03-31 $235,804 4,957
2025-12-31 $264,664 5,047
2025-09-30 $334,095 5,155
2025-06-30 $265,331 5,455
2024-03-31 $201,958 2,963
2023-12-31 $224,295 3,583
2023-12-31 $5,160 1,200
2021-09-30 $227,777 2,035
2021-06-30 $32,000 2,100
2021-06-30 $305,162 1,885
2021-03-31 $48,740 400
2021-03-31 $212,019 1,740